Why MoonLake Immunotherapeutics Stock Shot Up 41.1% on Tuesday
Copyright 1995-2022 The Motley Fool. All rights reserved.
finance
2022-05-31 20:51:34

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company that specializes in therapies for inflammatory skin and joint diseases, saw its shares jump 41.1% on Tuesday.
The stock closed at $6.38 on Friday, then opened at $7.55 on Tuesday after the Memorial Day weekend, before rising to a high of $9 just after the opening bell. The stock has a 52-week high of $15.19 and a low of $4.25, and is down more than 25% this year.

Image source: Getty Images.

So what
Tuesday's run-up is a continuation of a 25.
